Last reviewed · How we verify

NCT05293652

Effect of Hydrocortisone Iontophoresis Versus Hydrocortisone Phonophoresis On Post Surgical Scar

Completed NA Last updated 24 March 2022
What this trial tests

NA trial testing Iontophoresis in Scar in 60 participants. Completed in 15 February 2022.

Timeline
1 September 2021
Primary endpoint
15 January 2022
15 February 2022

Quick facts

Lead sponsorHorus University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date1 September 2021
Primary completion15 January 2022
Estimated completion15 February 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Horus University

Who can join

Adults 20 to 35, any sex, with Scar or Hydrocortisone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study will be to compare the effect of hydrocortisone iontophoresis and hydrocortisone phonophoresis on the treatment of surgical scar and overall scar appearance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Iontophoresis

Trials testing the same drug.

Other recruiting trials for Scar

Currently open trials in the same condition.

Other Horus University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05293652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing